Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alshaima’a M. Qunies
Observed names:
Alshaima'a M Qunies,
Alshaima'a M. Qunies,
Alshaimaa M. Qunies,
Alshaima’a M Qunies
Institution:
Drug Hunter
Observed institutions:
University of North Texas,
University of North Texas Health Science Center,
German Jordanian University,
University of North Texas System,
Drug Hunter
ORCID:
0000-0003-4922-8682
Observed ORCID:
0000-0003-4922-8682
OpenAlex ID:
A5074801613
Perceptions of Chemical Safety in Laboratories
2019
·
Walid Al-Zyoud
, Alshaimaa M. Qunies
, et al.
·
Safety
·
77
PDF
VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons
2020
·
Brittany D. Spitznagel
, Nigam M. Mishra
, et al.
·
ACS Chemical Neuroscience
·
55
Property-Based Drug Design Merits a Nobel Prize
2024
·
Lewis D. Pennington
, Matthew J. Hesse
, et al.
·
Journal of Medicinal Chemistry
·
37
Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685
2023
·
Alshaima'a M. Qunies
, Brittany D. Spitznagel
, et al.
·
Bioorganic & Medicinal Chemistry
·
18
PDF
Small-Molecule Inhibitors of Slack Potassium Channels As Potential Therapeutics for Childhood Epilepsies
2022
·
Alshaima'a M Qunies
, Kyle A Emmitte
·
Pharmaceutical Patent Analyst
·
16
Structure–Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels
2024
·
Alshaima’a M. Qunies
, Brittany D. Spitznagel
, et al.
·
Molecules
·
12
Structure–activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels
2022
·
Alshaima'a M. Qunies
, Nigam M. Mishra
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
12
PDF
Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on somatostatin- and parvalbumin-expressing cortical GABAergic neurons
2024
·
Amy N. Shore
, Keyong Li
, et al.
·
eLife
·
11
Negative allosteric modulators of group II metabotropic glutamate receptors: A patent review (2015 – present)
2021
·
Alshaima’a M. Qunies
, Kyle A. Emmitte
·
Expert Opinion on Therapeutic Patents
·
10
Author response: Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on SST- and PV-expressing cortical GABAergic neurons
2024
·
Amy N Shore
, Keyong Li
, et al.
·
eLife
·
3
Strategic Use of the Necessary Nitrogen Atom for Holistic Property-Based Drug Design
2026
·
Lewis D. Pennington
, Julia M. Clay
, et al.
·
Journal of Medicinal Chemistry
·
2
Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on SST- and PV-expressing cortical GABAergic neurons
2024
·
Amy N Shore
, Keyong Li
, et al.
·
eLife
·
2
PDF
Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on SST- and PV-expressing cortical GABAergic neurons
2024
·
Amy N. Shore
, Alshaima’a M. Qunies
, et al.
·
eLife
·
2
PDF
Author response: Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on somatostatin- and parvalbumin-expressing cortical GABAergic neurons
2024
·
Amy N Shore
, Keyong Li
, et al.
·
eLife
Author response: Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on SST- and PV-expressing cortical GABAergic neurons
2024
·
Amy N Shore
, Keyong Li
, et al.
·
eLife
Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on SST- and PV-expressing cortical GABAergic neurons
2024
·
Amy N Shore
, Keyong Li
, et al.
·
eLife
Show more works
View as search
Works count:
16
Citation count:
257
H-index:
9
I10-index:
9
Year
Topic
Type